Invesco BulletShares 2028 Corporate Bond ETF (NASDAQ:BSCS – Get Free Report) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 463,100 shares, a growth of 49.1% from the November 15th total of 310,500 shares. Based on an average daily volume of 465,100 shares, the days-to-cover ratio is currently 1.0 days.
Invesco BulletShares 2028 Corporate Bond ETF Stock Down 0.1 %
BSCS stock traded down $0.02 on Friday, hitting $20.27. 331,948 shares of the company’s stock were exchanged, compared to its average volume of 437,375. The firm has a 50 day moving average price of $20.29 and a two-hundred day moving average price of $20.28. Invesco BulletShares 2028 Corporate Bond ETF has a 12-month low of $19.65 and a 12-month high of $20.70.
Invesco BulletShares 2028 Corporate Bond ETF Increases Dividend
The business also recently disclosed a dividend, which was paid on Friday, November 22nd. Stockholders of record on Monday, November 18th were issued a dividend of $0.0761 per share. The ex-dividend date was Monday, November 18th. This is an increase from Invesco BulletShares 2028 Corporate Bond ETF’s previous dividend of $0.01.
Hedge Funds Weigh In On Invesco BulletShares 2028 Corporate Bond ETF
Invesco BulletShares 2028 Corporate Bond ETF Company Profile
The Invesco BulletShares 2028 Corporate Bond ETF (BSCS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a market-value-weighted index of USD-denominated corporate investment-grade bonds with effective maturities in 2028. BSCS was launched on Aug 9, 2018 and is managed by Invesco.
Featured Stories
- Five stocks we like better than Invesco BulletShares 2028 Corporate Bond ETF
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Why is the Ex-Dividend Date Significant to Investors?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Is WallStreetBets and What Stocks Are They Targeting?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Invesco BulletShares 2028 Corporate Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco BulletShares 2028 Corporate Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.